Clinical Data Milestone Highlights Potential for Cagent Vascular’s Limb-Salvage Therapy

According to a recent LinkedIn post from Cagent Vascular Inc, the company is highlighting new peer‑reviewed clinical data on its Serration Remodeling Therapy (SRT) in below‑the‑ankle, pedal vessels. The post points to publication in the Journal of Endovascular Therapy, describing it as the largest reported series involving a specialty balloon in this anatomy and emphasizing both luminal gain and a reported safety profile.

The LinkedIn post suggests that the ability to deliver SRT precisely in these challenging arteries may expand treatment options for patients at high risk of limb loss. For investors, externally published data in a respected clinical journal can support physician adoption and reimbursement discussions, potentially strengthening the company’s competitive position in limb‑salvage and endovascular therapy markets over the medium term.